S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Monopar Therapeutics (MNPR) Insider Trading & Ownership

$0.68
+0.02 (+3.04%)
(As of 04/18/2024 ET)

Monopar Therapeutics (NASDAQ:MNPR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
41.60%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$18,159.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get MNPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MNPR Insider Buying and Selling by Quarter

Monopar Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2022Andrew CittadineCOOBuy6,053$3.00$18,159.00  
(Data available from 1/1/2013 forward)

MNPR Insider Trading Activity - Frequently Asked Questions

Who is on Monopar Therapeutics's Insider Roster?

The list of insiders at Monopar Therapeutics includes Andrew Cittadine. Learn more on insiders at MNPR.

What percentage of Monopar Therapeutics stock is owned by insiders?

41.60% of Monopar Therapeutics stock is owned by insiders. Learn more on MNPR's insider holdings.

Which Monopar Therapeutics insiders have been buying company stock?

The following insider purchased MNPR shares in the last 24 months: Andrew Cittadine ($18,159.00).

How much insider buying is happening at Monopar Therapeutics?

Insiders have purchased a total of 6,053 MNPR shares in the last 24 months for a total of $18,159.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:MNPR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners